Celgene (CELG) - 27 Year Stock Price History

Historical daily stock prices for Celgene since 1990 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Celgene (CELG) as of August 22, 2017 is 130.29.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $99.695B $11.229B
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.